Elisa Buzzatti | Medicine | Research Excellence Award

Published on by Plant Scientist

Dr. Elisa Buzzatti | Medicine | Research Excellence Award

University Tor Vergata | Italy

Elisa Buzzatti is a physician–scientist and hematologist with advanced training in medical biotechnology and translational medicine. She earned her medical degree and specialization in Hematology at the University of Rome “Tor Vergata” and is currently enrolled in a doctoral program in Medical Biotechnology and Translational Medicine. Her clinical and research experience spans stem cell transplantation, acute and chronic leukemias, myeloproliferative disorders, and phase II–III clinical trials. She has contributed to numerous high-impact, peer-reviewed international publications and multicenter studies. Her research focuses on leukemia biology, immunotherapy, infectious complications, and measurable residual disease, aiming to improve precision and outcomes in hematologic malignancies.

                    Citation Metrics (Scopus)

400

300

200

100

10

0

 

Citations
241
Documents
35
h-index
10

Citations

Documents

h-index

View Scopus Profile   View Google Scholar Profile

Featured Publications

Bernard Tardy | Women’s Health | Research Excellence Award

Published on by Plant Scientist

Prof. Dr. Bernard Tardy | Women’s Health | Research Excellence Award

Clinical Investigation Center, Inserm 1408 | France

Dr Bernard Tardy is MD and Professor of Therapeutics at Université Jean Monnet (Saint-Étienne, France) and until 2018 served as Head of the Medical Intensive Care Unit at the University Hospital Center in Saint-Étienne. Since 2014 he coordinates the clinical research group INSERM CIC 1408 (Centre d’Investigation Clinique) and has since 2020 also served as a scientific advisor to HCERES (the High Council for Evaluation of Research and Higher Education), and since 2022 as scientific advisor to FCRIN (French Clinical Research Infrastructure Network). His clinical-research interests lie in anticoagulation, thrombosis, bleeding risk, haemostasis and critical care medicine, as illustrated by his recent work on bleeding risk in palliative care (the “RHESO” study), heparin-induced thrombocytopenia diagnosis and management, and thrombotic/bleeding risk in haemophilia and haematological malignancies. Over his career he has authored around 13 peer-reviewed clinical and translational research articles (as per your count), this combination has contributed to improvements in diagnosis and management of anticoagulation, patient safety, and evidence-based care.

Profile: Orcid

Featured Publications

Tardy‐Poncet, B., Montmartin, A., Chambost, H., Lienhart, A., Frotscher, B., Morange, P.-E., Falaise, C., Collange, F., Dargaud, Y., Toussaint‐Hacquard, M., Ardillon, L., Wibaut, B., Jeanpierre, E., Nguyen, P., Volot, F., & Tardy, B. (2024). Relationship between plasma tissue Factor Pathway Inhibitor (TFPI) levels, thrombin generation and clinical risk of bleeding in patients with severe haemophilia A or B. Haemophilia.

Dericquebourg, A., Fretigny, M., Chatron, N., Tardy, B., Zawadzki, C., Chambost, H., Vinciguerra, C., & Jourdy, Y. (2023). Whole F9 gene sequencing identified deep intronic variations in genetically unresolved hemophilia B patients. Journal of Thrombosis and Haemostasis.

De Mazancourt, P., Harroche, A., Pouymayou, K., Sigaud, M., Falaise, C., Stieltjes, N., Castet, S.-M., Tardy, B., Zawadzki, C., & Goudemand, J. (2023). Reinvestigation of unidentified causative variants in FXI‐deficient patients: Focus on gene segment deletions. Haemophilia.

Crépin, R., Morin, C., Montmartin, A., Tardy-Poncet, B., & Chelle, P. (2021). Use of population PK/PD approach to model the thrombin generation assay: Assessment in haemophilia A plasma samples spiked by a TFPI antibody. Journal of Pharmacokinetics and Pharmacodynamics.

Lockhart, M., Tardy-Poncet, B., Montmartin, A., Noyel, P., Thouvenin, S., & Berger, C. (2021). Surgery with emicizumab prophylaxis for two paediatric patients with severe haemophilia A with inhibitors. Pediatric Blood & Cancer.

Dekui Zhang | Host-Pathogen Interactions | Best Researcher Award

Published on by Plant Scientist

Prof. Dr. Dekui Zhang | Host-Pathogen Interactions | Best Researcher Award

The Second Hospital of Lanzhou University | China

Prof. Dr. De-Kui Zhang is a distinguished gastroenterologist and Principal Investigator recognized for his extensive research in Helicobacter pylori infection, inflammatory bowel disease (IBD), gastrointestinal motility disorders, and behavioral gastroenterology. He received advanced academic training in clinical gastroenterology and molecular pathogenesis, progressing to a leading research and academic role in China. With over h-index of 19, 1345 citations, and 116 total documents, he has significantly shaped current understanding of host–pathogen interactions and chronic microbial infection. He has including four NSFC grants, advancing molecular models of microbial pathogenesis and contributing to clinical diagnostic innovations. His scholarly contributions include co-editing the academic volume Health Management of Gastritis, while his leadership roles in national academic committees—particularly within the Helicobacter pylori Group of the Chinese Society of Gastroenterology—underscore his influence on clinical guidelines and national research priorities. His work has been recognized with prestigious distinctions such as the Gansu Provincial Scientific Progress Second Prize, highlighting his impact on improving digestive health outcomes. Prof. Zhang continues to mentor emerging medical scientists and strengthen national collaborations, contributing broadly to translational gastroenterology research and patient care advancement.

Profiles: Scopus | Orcid

Featured Publications

Ma, X., Li, M., Wang, X., Xu, H., Jiang, L., Wu, F., Wei, L., Qi, G., & Zhang, D. (2024). Dihydromyricetin ameliorates experimental ulcerative colitis by inhibiting neutrophil extracellular traps formation via the HIF-1α/VEGFA signaling pathway. International Immunopharmacology.

Liu, N., Luo, Q., Gou, L., Shen, X., & Zhang, D. (2024). Knowledge and practices of Helicobacter pylori infection management among physicians in Gansu Province, China: A cross-sectional study. Helicobacter.

Gou, L., Yang, X., Yun, J., Ma, Z., Zheng, X., Du, H., & Zhang, D. (2024). Roles of the components of the cag-pathogenicity island encoded type IV secretion system in Helicobacter pylori. Future Microbiology. Advance online publication.

Ma, X., Li, J., Li, M., Qi, G., Wei, L., & Zhang, D. (2024). NETs in fibrosis: Bridging innate immunity and tissue remodeling. International Immunopharmacology.

Xu, H., Huang, K., Shi, M., Gong, H., Han, M., Tian, W., Wang, X., & Zhang, D. (2024). MicroRNAs in Helicobacter pylori-infected gastric cancer: Function and clinical application. Pharmacological Research,